Ms. Quinlivan represents people who have been injured as a result of taking prescription medications, by medical devices or other defective products. Over the past several years Ms. Quinlivan served as a member of discovery and law and briefing teams in the In re: Testosterone Replacement Therapy Products Liability Litigation (MDL 2595) before Hon. Matthew Kennelly (USDC-NDIL). She and her colleagues tried two cases to verdict, and our mass tort team is presently working to guide a number of clients through the settlement process for their TRT claims. Previously, Ms. Quinlivan served as a member of the Plaintiffs’ Steering Committee for the In re: Power Morcellator Multidistrict Litigation (MDL 2652) overseen by the Honorable Kathryn H. Vratil (Chief Judge of the United States District Court for the District of Kansas). Ms. Quinlivan works closely with Co-Lead Counsel and Discovery Committee Co-Chairs in the In re: Yasmin and Yaz Marketing, Sales Practices, and Products Liability Litigation (MDL 2100) and for In re: Pradaxa Products Liability Litigation (MDL 2385), pending in the U.S. District Court for the Southern District of Illinois, before the Honorable David R. Herndon.